Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $802,635 - $993,433
-6,742 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $44,585 - $55,223
-417 Reduced 5.82%
6,742 $886,000
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $8,116 - $8,828
76 Added 1.07%
7,159 $801,000
Q2 2019

Aug 05, 2019

SELL
$110.79 - $129.32 $81,652 - $95,308
-737 Reduced 9.42%
7,083 $785,000
Q1 2019

Apr 18, 2019

SELL
$111.31 - $131.02 $17,809 - $20,963
-160 Reduced 2.01%
7,820 $1.02 Million
Q4 2018

Jan 22, 2019

BUY
$105.9 - $118.64 $41,195 - $46,150
389 Added 5.12%
7,980 $923,000
Q3 2018

Oct 25, 2018

SELL
$85.86 - $107.31 $19,318 - $24,144
-225 Reduced 2.88%
7,591 $815,000
Q2 2018

Jul 19, 2018

BUY
$75.7 - $86.88 $324,071 - $371,933
4,281 Added 121.1%
7,816 $667,000
Q1 2018

Apr 27, 2018

BUY
$74.21 - $87.6 $30,055 - $35,478
405 Added 12.94%
3,535 $273,000
Q4 2017

Jan 31, 2018

BUY
$81.94 - $87.89 $327 - $351
4 Added 0.13%
3,130 $264,000
Q3 2017

Oct 19, 2017

BUY
$77.07 - $85.54 $385 - $427
5 Added 0.16%
3,126 $267,000
Q2 2017

Aug 10, 2017

SELL
N/A
-836 Reduced 21.13%
3,121 $257,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,957
3,957 $333,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mycio Wealth Partners, LLC Portfolio

Follow Mycio Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mycio Wealth Partners, LLC with notifications on news.